ICE vs RNAC · P/E 37, rev $12.64B vs P/E 2.1, rev $38.9M
Intercontinental Exchange Inc (ICE) versus Cartesian Therapeutics Inc. (RNAC) — a side-by-side from cached financials, not a winner call.
Intercontinental Exchange Inc (ICE) is a financial data & stock exchanges company listed on US.
Cartesian Therapeutics Inc. (RNAC) is a biotechnology company listed on US.
Latest reported ICE revenue for 2025-12-31 was $12.64B. Net income was $3.31B. Revenue was up 7.5% from 2024-12-31 to 2025-12-31. ICE currently screens at market cap $103.55B and trailing P/E 37.3.
Latest reported RNAC revenue for 2024-12-31 was $38.9M. Net income was -$77.4M. Revenue was up 49.6% from 2023-12-31 to 2024-12-31. RNAC currently screens at market cap $290.9M and trailing P/E 2.1.
ICE currently screens at market cap $103.55B and trailing P/E 37.3. RNAC currently screens at market cap $290.9M and trailing P/E 2.1.
Not investment advice. Open the ICE and RNAC stock pages for the full models.
Not investment advice.